Fibronectin splice variants: Understanding their multiple roles in health and disease using engineered mouse models

IUBMB Life

Volumn 63, Issue 7, 2011, Pages 538-546

  White, Eric S ^a   Muro, Andrés F ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

alternative splicing; complex diseases; disease models; genetic models; protein function

Indexed keywords

ALPHA4 INTEGRIN; FIBRONECTIN; FIBRONECTIN SPLICE VARIANT; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL MODEL; AORTA ANEURYSM; CELL DIFFERENTIATION; EMBRYO DEVELOPMENT; ENZYME INDUCTION; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROSIS; FOCAL ADHESION; GENE DELETION; GENE MUTATION; HEMOSTASIS; HUMAN; IN VIVO STUDY; LIGAND BINDING; MORPHOGENESIS; MYOFIBROBLAST; NONHUMAN; PATHOLOGY; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; THROMBOSIS;

ALTERNATIVE SPLICING; ANIMALS; DISEASE; EXTRACELLULAR MATRIX; FIBRONECTINS; FIBROSIS; HUMANS; MICE; PROTEIN CONFORMATION; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION;

EID: 79959596406     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.493     Document Type: Review

References (75)

1. Discher, D. E., Mooney, D. J., and, Zandstra, P. W., (2009) Growth factors, matrices, and forces combine and control stem cells. Science 324, 1673-1677.
2. Geiger, B., Spatz, J. P., and, Bershadsky, A. D., (2009) Environmental sensing through focal adhesions. Nat. Rev. Mol. Cell Biol. 10, 21-33.
3. Bateman, J. F., Boot-Handford, R. P., and, Lamande, S. R., (2009) Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations. Nat. Rev. Genet. 10, 173-183.
4. Castelletti, F., Donadelli, R., Banterla, F., Hildebrandt, F., Zipfel, P. F., et al. (2008) Mutations in FN1 cause glomerulopathy with fibronectin deposits. Proc. Natl. Acad. Sci. USA 105, 2538-2543. (Pubitemid 351520549)
5. Astrof, S., Crowley, D., and, Hynes, R. O., (2007) Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. Dev. Biol. 311, 11-24. (Pubitemid 47588228)
6. Fukuda, T., Yoshida, N., Kataoka, Y., Manabe, R., Mizuno-Horikawa, Y., et al. (2002) Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell growth and fibronectin matrix assembly in vitro. Cancer Res. 62, 5603-5610.
7. George, E. L., Georges-Labouesse, E. N., Patel-King, R. S., Rayburn, H., and, Hynes, R. O., (1993) Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119, 1079-1091. (Pubitemid 23358578)
8. Georges-Labouesse, E. N., George, E. L., Rayburn, H., and, Hynes, R. O., (1996) Mesodermal development in mouse embryos mutant for fibronectin. Dev. Dyn. 207, 145-156. (Pubitemid 26362206)
9. Muro, A. F., Chauhan, A. K., Gajovic, S., Iaconcig, A., Porro, F., et al. (2003) Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J. Cell Biol. 162, 149-160. (Pubitemid 36859542)
10. Sakai, T., Johnson, K. J., Murozono, M., Sakai, K., Magnuson, M. A., et al. (2001) Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat. Med. 7, 324-330. (Pubitemid 32224348)
11. Takahashi, M., Saito, H., Higashimoto, M., and, Hibi, T., (2007) Possible inhibitory effect of oral zinc supplementation on hepatic fibrosis through downregulation of TIMP-1: a pilot study. Hepatol. Res. 37, 405-409. (Pubitemid 46915784)
12. Tan, M. H., Sun, Z., Opitz, S. L., Schmidt, T. E., Peters, J. H., et al. (2004) Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood 104, 11-18. (Pubitemid 38879830)
13. Hynes, R. O., (1990) Fibronectins. Springer-Verlag, New York.
14. White, E. S., Baralle, F. E., and, Muro, A. F., (2008) New insights into form and function of fibronectin splice variants. J. Pathol. 216, 1-14.
15. Gilbert, W., (1978) Why genes in pieces? Nature 271, 501.
16. Hynes, R. O., (2007) Cell-matrix adhesion in vascular development. J. Thromb. Haemost. 5 (Suppl 1), 32-40. (Pubitemid 46964284)
17. Chauhan, A. K., Iaconcig, A., Baralle, F. E., and, Muro, A. F., (2004) Alternative splicing of fibronectin: a mouse model demonstrates the identity of in vitro and in vivo systems and the processing autonomy of regulated exons in adult mice. Gene 324, 55-63. (Pubitemid 38030325)
18. Peters, J. H., and, Hynes, R. O., (1996) Fibronectin isoform distribution in the mouse. I. The alternatively spliced EIIIB, EIIIA, and V segments show widespread codistribution in the developing mouse embryo. Cell Adhes. Commun. 4, 103-125.
19. Magnuson, V. L., Young, M., Schattenberg, D. G., Mancini, M. A., Chen, D. L., et al. (1991) The alternative splicing of fibronectin pre-mRNA is altered during aging and in response to growth factors. J. Biol. Chem. 266, 14654-14662. (Pubitemid 21907552)
20. Pagani, F., Zagato, L., Vergani, C., Casari, G., Sidoli, A., and, Baralle, F. E., (1991) Tissue-specific splicing pattern of fibronectin messenger RNA precursor during development and aging in rat. J. Cell Biol. 113, 1223-1229. (Pubitemid 21909752)
21. Moretti, F. A., Chauhan, A. K., Iaconcig, A., Porro, F., Baralle, F. E., and, Muro, A. F., (2007) A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived. J. Biol. Chem. 282, 28057-28062. (Pubitemid 47529518)
22. Ffrench-Constant, C., Van de Water, L., Dvorak, H. F., and, Hynes, R. O., (1989) Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J. Cell Biol. 109, 903-914. (Pubitemid 19197047)
23. Peters, J. H., Chen, G. E., and, Hynes, R. O., (1996) Fibronectin isoform distribution in the mouse. II. Differential distribution of the alternatively spliced EIIIB, EIIIA, and V segments in the adult mouse. Cell Adhes. Commun. 4, 127-148.
24. Carnemolla, B., Balza, E., Siri, A., Zardi, L., Nicotra, M. R., et al. (1989) A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J. Cell Biol. 108, 1139-1148. (Pubitemid 19083757)
25. Rybak, J. N., Roesli, C., Kaspar, M., Villa, A., and, Neri, D., (2007) The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res. 67, 10948-10957. (Pubitemid 350145924)
26. Castellani, P., Viale, G., Dorcaratto, A., Nicolo, G., Kaczmarek, J., et al. (1994) The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int. J. Cancer 59, 612-618. (Pubitemid 24358583)
27. Astrof, S., Crowley, D., George, E. L., Fukuda, T., Sekiguchi, K., et al. (2004) Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis. Mol. Cell. Biol. 24, 8662-8670. (Pubitemid 39245085)
28. Astrof, S., and, Hynes, R. O., (2009) Fibronectins in vascular morphogenesis. Angiogenesis 12, 165-175.
29. Bazigou, E., Xie, S., Chen, C., Weston, A., Miura, N., et al. (2009) Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev. Cell 17, 175-186.
30. Huang, X. Z., Wu, J. F., Ferrando, R., Lee, J. H., Wang, Y. L., et al. (2000) Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol. Cell. Biol. 20, 5208-5215. (Pubitemid 30431573)
31. Paloschi, V., Kurtovic, S., Folkersen, L., Gomez, D., Wagsater, D., et al. (2011) Impaired splicing of fibronectin is associated with thoracic aortic aneurysm formation in patients with bicuspid aortic valve. Arterioscler. Thromb. Vasc. Biol. 31, 691-697.
32. Babaev, V. R., Porro, F., Linton, M. F., Fazio, S., Baralle, F. E., and, Muro, A. F., (2008) Absence of regulated splicing of fibronectin EDA exon reduces atherosclerosis in mice. Atherosclerosis 197, 534-540. (Pubitemid 351417892)
33. Hernnas, J., Nettelbladt, O., Bjermer, L., Sarnstrand, B., Malmstrom, A., and, Hallgren, R., (1992) Alveolar accumulation of fibronectin and hyaluronan precedes bleomycin-induced pulmonary fibrosis in the rat. Eur. Respir. J. 5, 404-410.
34. Muro, A. F., Moretti, F. A., Moore, B. B., Yan, M., Atrasz, R. G., et al. (2008) An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 177, 638-645. (Pubitemid 351442171)
35. Jarnagin, W. R., Rockey, D. C., Koteliansky, V. E., Wang, S. S., and, Bissell, D. M., (1994) Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J. Cell Biol. 127, 2037-2048.
36. Serini, G., Bochaton-Piallat, M. L., Ropraz, P., Geinoz, A., Borsi, L., et al. (1998) The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J. Cell Biol. 142, 873-881. (Pubitemid 28381502)
37. Kohan, M., Muro, A. F., Bader, R., and, Berkman, N., (2011) The extra domain A of fibronectin is essential for allergen-induced airway fibrosis and hyperresponsiveness in mice. J. Allergy Clin. Immunol. 127, 439-446 e431-435.
38. Arslan, F., Smeets, M. B., Riem Vis, P. W., Karper, J. C., Quax, P. H., et al. (2011) Lack of Fibronectin-EDA Promotes Survival and Prevents Adverse Remodeling and Heart Function Deterioration After Myocardial Infarction. Circ. Res. 108, 582-592.
39. Balza, E., Borsi, L., Allemanni, G., and, Zardi, L., (1988) Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett. 228, 42-44. (Pubitemid 18039472)
40. Murphy-Ullrich, J. E., and, Poczatek, M., (2000) Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev. 11, 59-69. (Pubitemid 30169726)
41. Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J., Dalton, S. L., et al. (1999) The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96, 319-328. (Pubitemid 29077586)
42. Blakytny, R., Ludlow, A., Martin, G. E., Ireland, G., Lund, L. R., et al. (2004) Latent TGF-beta1 activation by platelets. J. Cell. Physiol. 199, 67-76.
43. Fontana, L., Chen, Y., Prijatelj, P., Sakai, T., Fassler, R., et al. (2005) Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1. FASEB J. 19, 1798-1808. (Pubitemid 41598764)
44. Peters, J. H., Maunder, R. J., Woolf, A. D., Cochrane, C. G., and, Ginsberg, M. H., (1989) Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury. J. Lab. Clin. Med. 113, 586-597. (Pubitemid 19128729)
45. Cho, J., and, Mosher, D. F., (2006) Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi. Blood 107, 3555-3563.
46. Ni, H., Papalia, J. M., Degen, J. L., and, Wagner, D. D., (2003) Control of thrombus embolization and fibronectin internalization by integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain. Blood 102, 3609-3614. (Pubitemid 37409378)
47. Matuskova, J., Chauhan, A. K., Cambien, B., Astrof, S., Dole, V. S., et al. (2006) Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles. Arterioscler. Thromb. Vasc. Biol. 26, 1391-1396. (Pubitemid 44305387)
48. Castellanos, M., Leira, R., Serena, J., Blanco, M., Pedraza, S., et al. (2004) Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke 35, 1671-1676. (Pubitemid 38823645)
49. van der Plas, R. M., Schiphorst, M. E., Huizinga, E. G., Hene, R. J., Verdonck, L. F., et al. (1999) von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood 93, 3798-3802. (Pubitemid 29249826)
50. Vincent, P. A., Rebres, R. A., Lewis, E. P., Hurst, V. t., and, Saba, T. M., (1993) Release of ED1 fibronectin from matrix of perfused lungs after vascular injury is independent of protein synthesis. Am. J. Physiol. 265, L485-492. (Pubitemid 23345036)
51. Kanters, S. D., Banga, J. D., Algra, A., Frijns, R. C., Beutler, J. J., and, Fijnheer, R., (2001) Plasma levels of cellular fibronectin in diabetes. Diabetes Care 24, 323-327. (Pubitemid 32119132)
52. Chauhan, A. K., Kisucka, J., Cozzi, M. R., Walsh, M. T., Moretti, F. A., et al. (2008) Prothrombotic effects of fibronectin isoforms containing the EDA domain. Arterioscler. Thromb. Vasc. Biol. 28, 296-301. (Pubitemid 351161203)
53. Tomasini-Johansson, B., and, Mosher, D. F., (2009) Plasma fibronectin concentration in inbred mouse strains. Thromb. Haemost. 102, 1278-1280.
54. Pecheniuk, N. M., Elias, D. J., Deguchi, H., Averell, P. M., and, Griffin, J. H., (2008) Elevated plasma fibronectin levels associated with venous thromboembolism. Thromb. Haemost. 100, 224-228.
55. Hynes, R. O., (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687. (Pubitemid 35283958)
56. Chi-Rosso, G., Gotwals, P. J., Yang, J., Ling, L., Jiang, K., et al. (1997) Fibronectin type III repeats mediate RGD-independent adhesion and signaling through activated beta1 integrins. J. Biol. Chem. 272, 31447-31452. (Pubitemid 28013283)
57. Korom, S., Hancock, W. W., Coito, A. J., and, Kupiec-Weglinski, J. W., (1998) Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients. II. Treatment with connecting segment-1 peptides prevents chronic rejection by attenuating arteriosclerotic development and suppressing intragraft T cell and macrophage activation. Transplantation 65, 854-859. (Pubitemid 28160679)
58. Liao, Y. F., Gotwals, P. J., Koteliansky, V. E., Sheppard, D., and, Van De Water, L., (2002) The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J. Biol. Chem. 277, 14467-14474. (Pubitemid 34952511)
59. Amersi, F., Shen, X. D., Moore, C., Melinek, J., Busuttil, R. W., et al. (2003) Fibronectin-alpha 4 beta 1 integrin-mediated blockade protects genetically fat Zucker rat livers from ischemia/reperfusion injury. Am. J. Pathol. 162, 1229-1239. (Pubitemid 36350667)
60. Johansson, S., Svineng, G., Wennerberg, K., Armulik, A., and, Lohikangas, L., (1997) Fibronectin-integrin interactions. Front. Biosci. 2, d126-d146.
61. Petrovic, A., Alpdogan, O., Willis, L. M., Eng, J. M., Greenberg, A. S., et al. (2004) LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease. Blood 103, 1542-1547. (Pubitemid 38168676)
62. Kohan, M., Muro, A. F., White, E. S., and, Berkman, N., (2010) EDA-containing cellular fibronectin induces fibroblast differentiation through binding to {alpha}4{beta}7 integrin receptor and MAPK/Erk 1/2-dependent signaling. FASEB J. 24, 4503-4512.
63. Singh, P., Reimer, C. L., Peters, J. H., Stepp, M. A., Hynes, R. O., and, Van De Water, L., (2004) The spatial and temporal expression patterns of integrin alpha9beta1 and one of its ligands, the EIIIA segment of fibronectin, in cutaneous wound healing. J. Invest. Dermatol. 123, 1176-1181. (Pubitemid 39586843)
64. Okamura, Y., Watari, M., Jerud, E. S., Young, D. W., Ishizaka, S. T., et al. (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276, 10229-10233.
65. Hollestelle, S. C., De Vries, M. R., Van Keulen, J. K., Schoneveld, A. H., Vink, A., et al. (2004) Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 109, 393-398. (Pubitemid 38139309)
66. Lasarte, J. J., Casares, N., Gorraiz, M., Hervas-Stubbs, S., Arribillaga, L., et al. (2007) The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo. J. Immunol. 178, 748-756. (Pubitemid 46098855)
67. Gondokaryono, S. P., Ushio, H., Niyonsaba, F., Hara, M., Takenaka, H., et al. (2007) The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J. Leukoc. Biol. 82, 657-665. (Pubitemid 47367158)
68. Lefebvre, J. S., Levesque, T., Picard, S., Pare, G., Gravel, A., et al. (2011) The extra domain a of fibronectin primes leukotriene biosynthesis and stimulates neutrophil migration through toll-like receptor 4 activation. Arthritis Rheum.
69. Desmouliere, A., Chaponnier, C., and, Gabbiani, G., (2005) Tissue repair,contraction, and the myofibroblast. Wound Repair Regen. 13, 7-12.
70. Serini, G., Bochaton-Piallat, M. L., Ropraz, P., Geinoz, A., Borsi, L., et al. (1998) The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J. Cell Biol. 142, 873-881. (Pubitemid 28381502)
71. Thannickal, V. J., Lee, D. Y., White, E. S., Cui, Z., Larios, J. M., et al. (2003) Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J. Biol. Chem. 278, 12384-12389. (Pubitemid 36800223)
72. Ding, Q., Gladson, C. L., Wu, H., Hayasaka, H., and, Olman, M. A., (2008) Focal adhesion kinase (FAK)-related non-kinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner. J. Biol. Chem. 283, 26839-26849.
73. Greenberg, R. S., Bernstein, A. M., Benezra, M., Gelman, I. H., Taliana, L., and, Masur, S. K., (2006) FAK-dependent regulation of myofibroblast differentiation. FASEB J. 20, 1006-1008.
74. White, E. S., Atrasz, R. G., Hu, B., Phan, S. H., Stambolic, V., et al. (2006) Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). Am. J. Respir. Crit. Care Med. 173, 112-121. (Pubitemid 43069796)
75. Chan, M. W., Arora, P. D., Bozavikov, P., and, McCulloch, C. A., (2009) FAK, PIP5KIgamma and gelsolin cooperatively mediate force-induced expression of alpha-smooth muscle actin. J. Cell Sci. 122, 2769-2781.